Brief: Synthaverse Signs Deal With CoraPharm For Distribution Of ONKO BCG 50 And ONKO BCG 100
Sept 5 (Reuters) - Synthaverse SA SVEP.WA :
* SIGNS DEAL WITH SERBIAN PHARMACEUTICAL COMPANY CORAPHARM
* DEAL ON COOPERATION IN FIELD OF REGISTRATION, SUPPLY AND
DISTRIBUTION OF COMPANY'S MEDICINAL PRODUCTS ONKO BCG 50 AND
ONKO BCG 100
* TOTAL MIN. VALUE OF ORDERS IN FIRST FIVE YEARS OF DEAL SET
BY
PARTIES AT EUR 4.4 MILLION
Source text for Eikon: ID:nEM7Ffgqta
Further company coverage: SVEP.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; 48 58 769 66 00;))
Recent news on Synthaverse SA
See all newsBrief: Synthaverse EGM To Vote On Share Capital Increase Via Series X Share Issue
Brief: Synthaverse Gets 45 Mln Zloty Loan From Polish Agency For Enterprise Development For Debt Refinancing
Brief: Synthaverse Receives Registration Certificate For Onko BCG Product In Paraguay Under Partnership With Blau
Brief: Synthaverse H1 Net Loss At 6.4 Mln Zlotys
Brief: Synthaverse Gets Poland's GIF Decision Extending Manufacturing For New Immunological Products Facility